CGM Legacy AgaMatrix has a track record of pioneering glucose monitoring technologies, including iPhone-connected meters and continuous glucose monitoring efforts. This presents a sales opportunity to partner on integrated CGM solutions and connected health ecosystems with retailers and pharma collaborators.

Retail & Pharma Existing relationships with major retailers (CVS, Kroger) and pharmaceutical companies (Sanofi, Perrigo) indicate a channel-ready path for new biosensor or meter innovations, as well as co-branded or white-label devices.

WaveSense Recent launches like WaveSense Presto and WaveSense KeyNote Pro signal ongoing product expansion in high-accuracy sensing and smarter glucose meters, offering upsell or expansion opportunities with current customers seeking advanced monitoring.

Innovative Biosensors AgaMatrix emphasizes biosensor technology and connected health; sales conversations can position solutions for hospital, clinic, and consumer health markets demanding precise sensing, data analytics, and app integrations.

Financials & Growth With mid-market revenue estimates and a funding stack, there is room to discuss scale partnerships, copromotion, or licensing opportunities with larger diabetes care players looking to accelerate time-to-market through AgaMatrix’s proven device ecosystem.